120 related articles for article (PubMed ID: 18306371)
1. Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
Lasithiotakis K; Leiter U; Meier F; Eigentler T; Metzler G; Moehrle M; Breuninger H; Garbe C
Cancer; 2008 Apr; 112(8):1795-804. PubMed ID: 18306371
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous melanoma: From pathogenesis to therapy (Review).
Leonardi GC; Falzone L; Salemi R; Zanghì A; Spandidos DA; Mccubrey JA; Candido S; Libra M
Int J Oncol; 2018 Apr; 52(4):1071-1080. PubMed ID: 29532857
[TBL] [Abstract][Full Text] [Related]
3. Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011.
Enninga EAL; Moser JC; Weaver AL; Markovic SN; Brewer JD; Leontovich AA; Hieken TJ; Shuster L; Kottschade LA; Olariu A; Mansfield AS; Dronca RS
Cancer Med; 2017 Oct; 6(10):2203-2212. PubMed ID: 28879661
[TBL] [Abstract][Full Text] [Related]
4. Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trials.
Joosse A; Collette S; Suciu S; Nijsten T; Patel PM; Keilholz U; Eggermont AM; Coebergh JW; de Vries E
J Clin Oncol; 2013 Jun; 31(18):2337-46. PubMed ID: 23690423
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in melanoma survival: female patients have a decreased risk of metastasis.
Joosse A; de Vries E; Eckel R; Nijsten T; Eggermont AM; Hölzel D; Coebergh JW; Engel J;
J Invest Dermatol; 2011 Mar; 131(3):719-26. PubMed ID: 21150923
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Baseline
Kalantari F; Mirshahvalad SA; Hoellwerth M; Schweighofer-Zwink G; Huber-Schönauer U; Hitzl W; Rendl G; Koelblinger P; Pirich C; Beheshti M
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201554
[TBL] [Abstract][Full Text] [Related]
7. Analysis and prediction of 5-year survival in patients with cutaneous melanoma: a model-based period analysis.
Zheng S; Yu H; Zheng X; Wu UT; Ming WK; Huang H; Song J; Zhang X; Lyu J; Deng L
Front Endocrinol (Lausanne); 2023; 14():1238086. PubMed ID: 38125787
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma.
Woo TE; Stukalin I; Ding PQ; Goutam S; Sander M; Ewanchuk B; Cheung WY; Heng DYC; Cheng T
Curr Oncol; 2023 Sep; 30(10):8936-8947. PubMed ID: 37887546
[No Abstract] [Full Text] [Related]
9. Assessing the quality of care for skin malignant melanoma on a global, regional, and national scale: a systematic analysis of the global burden of disease study from 1990 to 2019.
Liu M; Wu M; Liu X; Zhou J; Lan Y; Zhang H; Zhang X; Leng L; Zheng H; Li J
Arch Dermatol Res; 2023 Dec; 315(10):2893-2904. PubMed ID: 37773351
[TBL] [Abstract][Full Text] [Related]
10. A practical nomogram and risk stratification system predicting the cancer-specific survival for patients aged >50 with advanced melanoma.
Xi Q; Lu X; Zhang J; Wang D; Sun Y; Chen H
Front Oncol; 2023; 13():1166877. PubMed ID: 37519813
[TBL] [Abstract][Full Text] [Related]
11. Nischarin expression may have differing roles in male and female melanoma patients.
Ostojić M; Jevrić M; Mitrović-Ajtić O; Živić K; Tanić M; Čavić M; Srdić-Rajić T; Grahovac J
J Mol Med (Berl); 2023 Aug; 101(8):1001-1014. PubMed ID: 37382661
[TBL] [Abstract][Full Text] [Related]
12. Clinical, Dermoscopic, and Histological Characteristics of Melanoma Patients According to the Age Groups: A Retrospective Observational Study.
Słowińska M; Czarnecka I; Czarnecki R; Tatara P; Nasierowska-Guttmejer A; Lorent M; Cierniak S; Owczarek W
Life (Basel); 2023 Jun; 13(6):. PubMed ID: 37374151
[TBL] [Abstract][Full Text] [Related]
13. Gender Differences in Oxidative Stress in Relation to Cancer Susceptibility and Survival.
Allegra A; Caserta S; Genovese S; Pioggia G; Gangemi S
Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37371985
[TBL] [Abstract][Full Text] [Related]
14. InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma.
Orlow I; Sadeghi KD; Edmiston SN; Kenney JM; Lezcano C; Wilmott JS; Cust AE; Scolyer RA; Mann GJ; Lee TK; Burke H; Jakrot V; Shang P; Ferguson PM; Boyce TW; Ko JS; Ngo P; Funchain P; Rees JR; O'Connell K; Hao H; Parrish E; Conway K; Googe PB; Ollila DW; Moschos SJ; Hernando E; Hanniford D; Argibay D; Amos CI; Lee JE; Osman I; Luo L; Kuan PF; Aurora A; Gould Rothberg BE; Bosenberg MW; Gerstenblith MR; Thompson C; Bogner PN; Gorlov IP; Holmen SL; Brunsgaard EK; Saenger YM; Shen R; Seshan V; Nagore E; Ernstoff MS; Busam KJ; Begg CB; Thomas NE; Berwick M;
PLoS One; 2023; 18(4):e0269324. PubMed ID: 37011054
[TBL] [Abstract][Full Text] [Related]
15. The nerve growth factor-delivered signals in prostate cancer and its associated microenvironment: when the dialogue replaces the monologue.
Di Donato M; Giovannelli P; Migliaccio A; Castoria G
Cell Biosci; 2023 Mar; 13(1):60. PubMed ID: 36941697
[TBL] [Abstract][Full Text] [Related]
16. Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma.
Mattila K; Vihinen H; Karlsson A; Minn H; Vihinen P; Heervä E
Acta Derm Venereol; 2023 Feb; 103():adv00860. PubMed ID: 36748330
[TBL] [Abstract][Full Text] [Related]
17. An analysis of lactate dehydrogenase (LDH) levels in advanced stage IV melanoma of the skin: prognostic capabilities and demographic variability.
Desai AD; Chinta S; Yeh C; Shah VP; Shah R; Paskhover B; Schwartz RA
Arch Dermatol Res; 2023 May; 315(4):799-806. PubMed ID: 36318305
[TBL] [Abstract][Full Text] [Related]
18. Association of Sentinel Node Biopsy and Pathological Report Completeness with Survival Benefit for Cutaneous Melanoma and Factors Influencing Their Different Uses in European Populations.
Sant M; Magri MC; Maurichi A; Lillini R; Bento MJ; Ardanaz E; Guevara M; Innos K; Marcos-Gragera R; Rubio-Casadevall J; Sánchez Pérez MJ; Tumino R; Rugge M; Minicozzi P; The Melanoma Hr Study Working Group
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139539
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Gene Expression Analysis to Identify Differences and Similarities between Sex- and Stage-Stratified Melanoma Samples.
Chrysanthou E; Sehovic E; Ostano P; Chiorino G
Cells; 2022 Mar; 11(7):. PubMed ID: 35406661
[TBL] [Abstract][Full Text] [Related]
20. YK-4-279 Attenuates Progression of Pre-Existing Pigmented Lesions to Nodular Melanoma in a Mouse Model.
Huang L; Zhai Y; Fajardo CD; Lang D
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
